May 7, 2020

RoyalMax Biotechnology Canada Inc. Signs Cannabis Genetics Supply Agreement with Rangers Pharmaceuticals

Matica Enterprises is pleased to announce its subsidiary, RoyalMax, has entered into a Purchase Agreement with Rangers to acquire cannabis...
April 23, 2020

Matica Announces Delayed Filing of Annual Disclosure Documents Pursuant to OSC Blanket Instrument 51-502

Matica Enterprises Inc. (CSE:MMJ) (Frankfurt:39F) (OTCQB:MMJFF) will be delaying the filing and delivery of certain of its continuous disclosure documents.
February 25, 2020

Matica Subsidiary Receives Sales Licence

Matica is pleased to announce that its subsidiary has received both the Standard Processing and Sale For Medical Purposes Licences...
February 12, 2020

Matica’s Interest in RoyalMax Released

Matica Enterprises Inc. (CSE:MMJ) (Frankfurt:39N) (OTCQB:MMJFF) is pleased to announce that Matica has closed the RoyalMax Biotechnology Canada Inc. acquisition.
December 18, 2019

Matica Welcomes Roop Mundi To The Board

Matica Enterprises Inc. is pleased to welcome Mr. Roop Mundi to the board of directors of the Company, subject to...
December 4, 2019

Construction Permits Received for Hemmingford Greenhouse Project

Matica Enterprises Inc. is pleased to report that the Company has obtained construction permits for the greenhouse project in Hemmingford,...
November 6, 2019

RoyalMax Submits for Health Canada Sales and Processing Licence

Matica Enterprises Inc. is pleased to announce that RoyalMax Biotechnology Canada Inc. has submitted to Health Canada applications for amendments.